Clinical Trial Update: Linezolid Plus Standard of Care [NA]

View source ↗

Summary

A clinical trial is evaluating adding Linezolid to standard of care for Staphylococcus aureus bloodstream infections and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bloodstream Infection

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) | NA | Status: RECRUITING